The role of histone lysine methyltransferase NSD3 in cancer

Onco Targets Ther. 2018 Jul 5:11:3847-3852. doi: 10.2147/OTT.S166006. eCollection 2018.


The growing number of findings demonstrate that nuclear receptor suppressor of variegation, enhancer of zeste, and trithorax domain-containing 3 (NSD3) is amplified and overexpressed in multiple cancer types. Nevertheless, the biological roles of NSD3 in carcinogenesis have not been well understood. In this review, we summarize the current knowledge on the mechanisms underlying NSD3 regulation in different cancers. In addition, NSD3 may serve as a potential druggable target for selective cancer therapy in the future.

Keywords: NSD3; cancer; carcinogenesis.

Publication types

  • Review